It looks like you are coming from United States, but the current site you have selected to visit is Indonesia. Do you want to change sites?

Yes, please. No. Keep me on the current site.

Xylem Inc. reports strong fourth quarter and full year 2014 results, including double-digit growth in earnings per share

February 5, 2015

Company increases quarterly cash dividend by 10 percent

  • Fourth quarter 2014 adjusted net income was $114 million or $0.62 per share, up 11 percent over fourth quarter 2013; GAAP net income was $96 million or $0.52 per share
  • Full-year 2014 adjusted net income was $362 million or $1.97 per share, an increase of 18 percent; Full-year GAAP net income was $337 million or $1.83 per share
  • Xylem delivered $1.04 billion in fourth quarter 2014 revenue, growth of 6 percent organically
  • Xylem’s fourth quarter 2014 adjusted operating margin increased 70 basis points, resulting in six consecutive quarters of adjusted operating margin expansion
  • Company projects full-year 2015 adjusted EPS of $1.85 to $1.95 per share; Excluding the expected unfavorable impact of foreign exchange translation, adjusted earnings growth of 5 to 10 percent is expected on organic revenue growth of 1 to 3 percent

RYE BROOK, N.Y.--(BUSINESS WIRE)--Feb. 5, 2015-- Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported fourth quarter 2014 net income of $96 million, or $0.52 per share. Excluding the impact of restructuring, realignment and other special charges, the Company delivered adjusted net income of $114 million or $0.62 per share in the quarter, an 11-percent increase over the comparable period in 2013. Fourth quarter organic revenue grew 6 percent to $1.04 billion, reflecting stronger results from emerging markets and the U.S., as well as across all end markets. Fourth quarter adjusted operating margins improved 70 basis points, driven by higher volume and the impact of efficiency measures undertaken throughout the year.

For the full year 2014, Xylem generated $3.92 billion in revenue, an organic increase of 3 percent over 2013. Full-year reported net income was $337 million, or $1.83 per share, with an operating margin of 11.8 percent. Adjusted net income, which excludes the impact of restructuring, realignment and other special items, was $362 million or $1.97 per share. Xylem delivered a full-year 2014 adjusted operating margin of 12.9 percent. Free cash flow was $297 million, up 50 percent versus last year.

“Xylem delivered strong results in the fourth quarter, closing out 2014 with a clear strategic focus, stronger execution and a renewed drive in research and innovation,” said Patrick Decker, president and chief executive officer of Xylem. “We generated growth in each of our key regions in the fourth quarter, with notably strong results in China and the emerging markets in general. Solid growth in the U.S. and more effective execution across the company helped us to mitigate slower growth in Europe.”

Decker continued, “During 2015, we will continue to strengthen critical organization capabilities in the areas of commercial excellence, innovation and technology, and emerging markets in order to accelerate Xylem’s growth. Our commitment to building a continuous improvement culture across the organization will drive efficiencies and enable us to continue to expand margins and reinvest for growth in our business. Our core fundamentals are strong and our 2015 plan tracks well with our long-term commitments to grow the company and our shareholders’ return.”

Xylem today also announced that its Board of Directors declared a dividend in the amount of $0.1408 per share for the first quarter of 2015, an increase of 10 percent. The dividend is payable on March 18, 2015 to shareholders of record as of February 18, 2015.

Full-year 2015 Outlook

Xylem forecasts full-year 2015 revenue of approximately $3.7 billion, a decrease of 5 to 7 percent over the 2014 results, including the projected unfavorable impact of foreign exchange translation. On an organic basis, Xylem’s revenue growth is anticipated to be in the range of 1 to 3 percent.

Full-year 2015 adjusted operating income is expected to be in the range of $480 to $505 million, resulting in adjusted earnings per share of $1.85 to $1.95. This represents a decline of 1 to 6 percent from Xylem’s 2014 adjusted results. Excluding the projected unfavorable impact of foreign exchange translation, Xylem’s adjusted earnings per share growth is anticipated to be in the range of 5 to 10 percent. The company’s adjusted earnings outlook reflects projected restructuring and realignment costs of $20 million for the year.

Fourth Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its businesses serving clean water delivery, wastewater transport and treatment, dewatering and analytical instrumentation.

  • Fourth quarter 2014 revenue was $672 million, up 6 percent organically compared with the fourth quarter 2013, reflecting growth across all business lines and all geographic regions.
  • Fourth quarter adjusted operating income for the segment, which excludes $9 million of restructuring, realignment and other special items, was $113 million, a 2-percent improvement over the same period in 2013. Adjusted operating margin for the quarter expanded 30 basis points reflecting the benefits of cost reduction actions taken throughout the year.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in residential and commercial building services, industrial and agricultural applications.

  • Fourth quarter 2014 revenue increased 7 percent organically year-over-year to $370 million with growth coming from all applications, and exceptionally strong performances in the U.S. and emerging markets.
  • Fourth quarter adjusted operating income for the segment, which excludes $2 million of restructuring and realignment costs, was $50 million, 6 percent higher than the comparable period last year. Adjusted operating margin grew 40 basis points, reflecting the benefits of cost reduction actions taken throughout the year, partially offset by unfavorable foreign exchange translation impacts.

Supplemental information on Xylem’s fourth quarter and full year 2014 earnings and reconciliations for certain non-GAAP items is posted at investors.xyleminc.com.

About Xylem

Xylem (XYL) is a leading global water technology provider, enabling customers to transport, treat, test and efficiently use water in public utility, residential and commercial building services, industrial and agricultural settings. The company does business in more than 150 countries through a number of market-leading product brands, and its people bring broad applications expertise with a strong focus on finding local solutions to the world’s most challenging water and wastewater problems. Xylem is headquartered in Rye Brook, New York, with 2014 revenues of $3.9 billion and approximately 12,500 employees worldwide. Xylem was named to the Dow Jones Sustainability Index for the last three years for advancing sustainable business practices and solutions worldwide.

The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all -- that which occurs in nature. For more information, please visit us at www.xyleminc.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements, which generally are not historical in nature. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking.

These forward-looking statements include statements about the capitalization of Xylem Inc. (the “Company”), the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future – including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results – are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.

Factors that could cause results to differ materially from those anticipated include: economic, political and other risks associated with our international operations, including military actions, economic sanctions or trade embargoes that could affect customer markets, and non-compliance with laws, including foreign corrupt practice laws, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; ability to retain and attract key members of management; our relationship with and the performance of our channel partners; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; governmental investigations; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2013, and those described from time to time in subsequent reports filed with the Securities and Exchange Commission.

All forward-looking statements made herein are based on information currently available to the Company. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED INCOME STATEMENTS
(In Millions, except per share data)

 
        Unaudited        
Year Ended December 31,       2014   2013   2012
Revenue       $ 3,916     $ 3,837     $ 3,791
Cost of revenue       2,403     2,338     2,289
Gross profit       1,513     1,499     1,502
Selling, general and administrative expenses       920     986     914
Research and development expenses       104     104     106
Separation costs           4     22
Restructuring and asset impairment charges       26     42     17
Operating income       463     363     443
Interest expense       54     55     55
Other non-operating income (expense), net       1     (10 )  
Gain from sale of business       11        
Income before taxes       421     298     388
Income tax expense       84     70     91
Net income       $ 337     $ 228     $ 297
Earnings per share:                    
Basic       $ 1.84     $ 1.23     $ 1.60
Diluted       $ 1.83     $ 1.22     $ 1.59
Weighted average number of shares:                    
Basic       183.1     185.2     185.8
Diluted       184.2     186.0     186.2
Dividends declared per share       $ 0.5120     $ 0.4656     $ 0.4048
 
 

XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In Millions, except per share amounts)

 
      Unaudited      
December 31,     2014     2013
ASSETS              
Current assets:              
Cash and cash equivalents     $ 663     $ 533  
Receivables, less allowances for discounts and doubtful accounts of $34 and $31 in 2014 and 2013, respectively     771     817  
Inventories     486     475  
Prepaid and other current assets     144     143  
Deferred income tax assets     38     41  
Total current assets     2,102     2,009  
Property, plant and equipment, net     461     488  
Goodwill     1,635     1,718  
Other intangible assets, net     431     488  
Other non-current assets     235     193  
Total assets     $ 4,864     $ 4,896  
LIABILITIES AND STOCKHOLDERS’ EQUITY              
Current liabilities:              
Accounts payable     $ 338     $ 332  
Accrued and other current liabilities     481     479  
Short-term borrowings and current maturities of long-term debt     89     42  
Total current liabilities     908     853  
Long-term debt     1,199     1,199  
Accrued postretirement benefits     388     348  
Deferred income tax liabilities     158     191  
Other non-current accrued liabilities     84     64  
Total liabilities     2,737     2,655  
               
Stockholders’ equity:              
Common Stock — par value $0.01 per share:              
Authorized 750.0 shares, issued 188.9 and 187.6 shares in 2014 and 2013, respectively     2     2  
Capital in excess of par value     1,796     1,753  
Retained earnings     648     405  
Treasury stock – at cost 6.6 shares and 3.0 shares in 2014 and 2013, respectively     (220 )   (86 )
Accumulated other comprehensive income     (99 )   167  
Total stockholders’ equity     2,127     2,241  
Total liabilities and stockholders’ equity     $ 4,864     $ 4,896  
 
 

XYLEM INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Millions)

 
      Unaudited          
Year Ended December 31,     2014     2013   2012
Operating Activities                    
Net income     $ 337     $ 228     $ 297  
Adjustments to reconcile net income to net cash provided by operating activities:                    
Depreciation     95     99     94  
Amortization     47     51     48  
Deferred income taxes     (29 )   (14 )   1  
Share-based compensation     18     27     22  
Restructuring and asset impairment charges, net     26     42     17  
Gain from sale of business     (11 )        
Other, net     2     15     2  
Payments of restructuring     (26 )   (35 )   (9 )
Contributions to postretirement benefit plans     (35 )   (43 )   (46 )
Changes in assets and liabilities (net of acquisitions):                    
Changes in receivables     (37 )   (47 )   2  
Changes in inventories     (49 )   (39 )   5  
Changes in accounts payable     17     4     (4 )
Changes in accrued liabilities     3     18     (28 )
Changes in accrued taxes     25     20     (17 )
Net changes in other assets and liabilities     33     (2 )   12  
Net Cash — Operating activities     416     324     396  
Investing Activities                    
Capital expenditures     (119 )   (126 )   (112 )
Proceeds from the sale of property, plant and equipment     2     6     5  
Acquisitions of businesses and assets, net of cash acquired         (81 )   (41 )
Proceeds from sale of business     30          
Other, net     1     2     1  
Net Cash — Investing activities     (86 )   (199 )   (147 )
Financing Activities                    
Net transfer to former parent             (9 )
Issuance of short-term debt     52     39     13  
Principal payments of debt and capital lease obligations         (2 )   (14 )
Repurchase of common stock     (134 )   (73 )   (13 )
Proceeds from exercise of employee stock options     26     22     24  
Excess tax benefit from share based compensation     2     1      
Dividends paid     (94 )   (87 )   (75 )
Other, net     1          
Net Cash — Financing activities     (147 )   (100 )   (74 )
Effect of exchange rate changes on cash     (53 )   4     11  
Net change in cash and cash equivalents     130     29     186  
Cash and cash equivalents at beginning of year     533     504     318  
Cash and cash equivalents at end of year     $ 663     $ 533     $ 504  
Supplemental disclosure of cash flow information:                    
Cash paid during the year for:                    
Interest     $ 51     $ 51     $ 53  
Income taxes (net of refunds received)     $ 81     $ 65     $ 104  
 

Xylem Inc. Non-GAAP Measures

Management views key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, free cash flow, working capital, and backlog, among others. In addition, we consider certain measures to be useful to management and investors evaluating our operating performance for the periods presented, and provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operations as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of foreign currency fluctuations and contributions from acquisitions and divestitures. Divestitures include sales of portions of our business that did not meet the criteria for classification as a discontinued operation or insignificant portions of our business that we did not classify as a discontinued operation. The period-over-period change resulting from foreign currency fluctuations assumes no change in exchange rates from the prior period.

“Constant currency” defined as financial results adjusted for currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation, amortization expense, and share-based compensation. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude non-recurring restructuring and realignment costs, gain on sale of business and special charges.

"Adjusted Operating Income", "Adjusted Segment Operating Income", and “Adjusted EPS” defined as operating income, segment operating income and earnings per share, adjusted to exclude non-recurring restructuring and realignment costs, gain on sale of business, special charges and tax-related special items, as applicable.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of free cash flows does not consider non-discretionary cash payments, such as debt.

“Realignment costs” defined as non-recurring costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, relocation, travel and other costs.

“Special charges” defined as costs incurred by the Company associated with the settlement of legal proceedings with Xylem Group LLC and certain costs incurred for the change in chief executive officer made during the third quarter of 2013, as well as costs incurred in the fourth quarter of 2013 for the contractual indemnification of federal tax obligations to ITT and costs associated with a legal judgment arising from a historical acquisition matter.

 
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Order Growth
($ Millions)
               
      (As Reported - GAAP)   (As Adjusted - Organic)   Constant Currency
          (A)   (B)       (C)   (D)   (E) = B+C+D   (F) = E/A   (G) = (E - C) / A
                                       
              Change   % Change  

Acquisitions /

      Change   % Change    
      Orders   Orders   2014 v. 2013   2014 v. 2013  

Divestitures

  FX Contribution   Adj. 2014 v. 2013   Adj. 2014 v. 2013    
      2014   2013                            

Year Ended December 31

                                     
                                       
Xylem Inc.     4,021   3,912   109   3%   1   43   153   4%   4%
                                       
Water Infrastructure     2,511   2,443   68   3%   (8)   40   100   4%   4%
Applied Water     1,510   1,469   41   3%   9   3   53   4%   3%
                                       

Quarter Ended December 31

                                     
                                       
Xylem Inc.     970   986   (16)   -2%   4   46   34   3%   3%
                                       
Water Infrastructure     596   630   (34)   -5%   -   35   1   0%   0%
Applied Water     374   356   18   5%   4   11   33   9%   8%
                                       

Quarter Ended September 30

                                     
                                       
Xylem Inc.     1,027   955   72   8%   5   2   79   8%   8%
                                       
Water Infrastructure     664   601   63   10%   -   -   63   10%   10%
Applied Water     363   354   9   3%   5   2   16   5%   3%
                                       

Quarter Ended June 30

                                     
                                       
Xylem Inc.     1,031   1,009   22   2%   (1)   (8)   13   1%   1%
                                       
Water Infrastructure     654   629   25   4%   (1)   1   25   4%   4%
Applied Water     377   380   (3)   -1%   -   (8)   (11)   -3%   -3%
                                       

Quarter Ended March 31

                                     
                                       
Xylem Inc.     993   962   31   3%   (7)   3   27   3%   4%
                                       
Water Infrastructure     597   583   14   2%   (7)   4   11   2%   3%
Applied Water     396   379   17   4%   -   (2)   15   4%   4%
                         
 
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
               
      (As Reported - GAAP)   (As Adjusted - Organic)   Constant Currency
          (A)   (B)       (C)   (D)   (E) = B+C+D   (F) = E/A   (G) = (E - C) / A
                                       
              Change   % Change  

Acquisitions /

      Change   % Change    
      Revenue   Revenue   2014 v. 2013   2014 v. 2013  

Divestitures

  FX Contribution   Adj. 2014 v. 2013   Adj. 2014 v. 2013    
      2014   2013                            

Year Ended December 31

                                     
                                       
Xylem Inc.     3,916   3,837   79   2%   6   49   134   3%   3%
                                       
Water Infrastructure     2,442   2,384   58   2%   (6)   47   99   4%   4%
Applied Water     1,474   1,453   21   1%   12   2   35   2%   2%
                                       

Quarter Ended December 31

                                     
                                       
Xylem Inc.     1,042   1,033   9   1%   5   50   64   6%   6%
                                       
Water Infrastructure     672   673   (1)   0%   -   39   38   6%   6%
Applied Water     370   360   10   3%   5   11   26   7%   6%
                                       

Quarter Ended September 30

                                     
                                       
Xylem Inc.     963   965   (2)   0%   7   2   7   1%   0%
                                       
Water Infrastructure     602   602   -   0%   -   1   1   0%   0%
Applied Water     361   363   (2)   -1%   7   -   5   1%   -1%
                                       

Quarter Ended June 30

                                     
                                       
Xylem Inc.     1,005   960   45   5%   (1)   (7)   37   4%   4%
                                       
Water Infrastructure     616   577   39   7%   (1)   2   40   7%   7%
Applied Water     389   383   6   2%   -   (7)   (1)   0%   0%
                                       

Quarter Ended March 31

                                     
                                       
Xylem Inc.     906   879   27   3%   (5)   4   26   3%   4%
                                       
Water Infrastructure     552   532   20   4%   (5)   5   20   4%   5%
Applied Water     354   347   7   2%   -   (2)   5   1%   1%
 
 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)
                           
        Q4     YTD
       

2014

   

2013

   

2014

   

2013

Total Revenue        
• Total Xylem       1,042     1,033     3,916     3,837
• Water Infrastructure    

 

672     673     2,442     2,384
• Applied Water    

 

370     360     1,474     1,453
                           
Operating Income        
• Total Xylem       141     129     463     363
• Water Infrastructure    

 

104     99     321     263
• Applied Water    

 

48     43     193     175
• Total Segments       152     142     514     438
                           
Operating Margin        
• Total Xylem       13.5%     12.5%     11.8%     9.5%
• Water Infrastructure       15.5%     14.7%     13.1%     11.0%
• Applied Water       13.0%     11.9%     13.1%     12.0%
• Total Segments       14.6%     13.7%     13.1%     11.4%
                           
Special Charges        
• Total Xylem       -     4     -     24
• Water Infrastructure       -     4     -     4
• Applied Water       -     -     -     -
• Total Segments       -     4     -     4
                           
Restructuring & Realignment Costs        
• Total Xylem       12     12     43     64
• Water Infrastructure       9     8     29     48
• Applied Water       2     4     13     16
• Total Segments       11     12     42     64
                           
Adjusted Operating Income*        
• Total Xylem       153     145     506     451
• Water Infrastructure    

 

113     111     350     315
• Applied Water    

 

50     47     206     191
• Total Segments       163     158     556     506
                           
Adjusted Operating Margin*        
• Total Xylem       14.7%     14.0%     12.9%     11.8%
• Water Infrastructure       16.8%     16.5%     14.3%     13.2%
• Applied Water       13.5%     13.1%     14.0%     13.1%
• Total Segments       15.6%     15.3%     14.2%     13.2%
 

*Adjusted Operating Income excludes restructuring & realignment costs and special charges.

 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
 
           
      Q4 2013   Q4 2014
     

As Reported

 

Adjustments

     

Adjusted

 

As Reported

 

Adjustments

     

Adjusted

Total Revenue     1,033           1,033   1,042           1,042
Operating Income     129   16   a   145   141   12   d   153
Operating Margin     12.5%           14.0%   13.5%           14.7%
Interest Expense     (14)           (14)   (13)           (13)
Other Non-Operating Income (Expense)     (8)   8   b   -   -           -
Gain on sale of business     -           -   -   -       -
Income before Taxes     107   24       131   128   12       140
Provision for Income Taxes     (39)   11   c   (28)   (32)   6   c   (26)
Net Income     68   35       103   96   18       114
Diluted Shares     185.6           185.6   183.3           183.3
Diluted EPS     $ 0.37   $ 0.19       $ 0.56   $ 0.52   $ 0.10       $ 0.62
                                   
           
      Q4 YTD 2013   Q4 YTD 2014
     

As Reported

 

Adjustments

     

Adjusted

 

As Reported

 

Adjustments

     

Adjusted

Total Revenue     3,837           3,837   3,916           3,916
Operating Income     363   88   a   451   463   43   d   506
Operating Margin     9.5%           11.8%   11.8%           12.9%
Interest Expense     (55)           (55)   (54)           (54)
Other Non-Operating Income (Expense)     (10)   8   b   (2)   1           1
Gain on sale of business     -           -   11   (11)       -
Income before Taxes     298   96       394   421   32       453
Provision for Income Taxes     (70)   (13)   c   (83)   (84)   (7)   c   (91)
Net Income     228   83       311   337   25       362
Diluted Shares     186.0           186.0   184.2           184.2
Diluted EPS     $ 1.22   $ 0.45       $ 1.67   $ 1.83   $ 0.14       $ 1.97
 
     
a   Restructuring & realignment costs and special charges
b   Special charges
c   Net tax impact of restructuring & realignment costs, special charges and special tax items
d   Restructuring & realignment costs
     
 
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow
($ Millions)
               
               
        Year Ended
        2014     2013
               
Net Cash - Operating Activities       $ 416       $ 324  
               
Capital Expenditures         (119 )       (126 )
               
Free Cash Flow       $ 297       $ 198  
               
Net Income         337         228  
               
Gain on Sale of Business         11         -  
               
Net Income, excluding gain on sale of business       $ 326       $ 228  
               
Free Cash Flow Conversion         91 %       87 %
 

 

Source: Xylem Inc.

For Xylem Inc.
Media
Kelly McAndrew, +1-914-323-5969
Kelly.McAndrew@xyleminc.com
or
Investors
Phil DeSousa, +1-914-323-5930
Phil.DeSousa@xyleminc.com

Xylem